Labshake search
Citations for Toronto Research Chemical :
1 - 2 of 2 citations for Somatostatin Tumor Inhibiting Analog since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2022Quote: ... cells were treated with 5μM ATP analog 3-BrB-PP1 (Toronto Research Chemicals; A602985) during 18 °C incubation for 1.5 hr to inactivate Sty1 kinase activity before being collected ...
-
bioRxiv - Immunology 2022Quote: Homotypic or heterotypic tumor spheroids were treated with a MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-ARU, Toronto Research Chemicals, Canada), diluted in RPMI media ...